title: Effect of oral ALA supplementation on oxidative stress and insulin sensitivity among overweight/obese adults: a double-blinded, randomized, controlled, cross-over intervention trial.
authors.forename: Weili
authors.initials: W
authors.lastname: Yan
authors.forename: Nong
authors.initials: N
authors.lastname: Li
authors.forename: Xiaojuan
authors.initials: X
authors.lastname: Hu
authors.forename: Yongdi
authors.initials: Y
authors.lastname: Huang
authors.forename: Weiguo
authors.initials: W
authors.lastname: Zhang
authors.forename: Qian
authors.initials: Q
authors.lastname: Wang
authors.forename: Fugang
authors.initials: F
authors.lastname: Wang
authors.forename: Chenchen
authors.initials: C
authors.lastname: Wang
authors.forename: Xiaohu
authors.initials: X
authors.lastname: Zhai
authors.forename: Ruiwei
authors.initials: R
authors.lastname: Xu
authors.forename: Kai
authors.initials: K
authors.lastname: Yan
authors.forename: Xiuhua
authors.initials: X
authors.lastname: Ding
authors.forename: Xiaoling
authors.initials: X
authors.lastname: Wang
mesh_terms: D000284:Administration, Oral; D000328:Adult; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D008297:Male; D009765:Obesity / Q000188:drug therapy* / Q000378:metabolism; D050177:Overweight / Q000188:drug therapy / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects* / Q000502:physiology; D016896:Treatment Outcome; D017962:alpha-Linolenic Acid / Q000008:administration & dosage*
chemical_list: D017962:alpha-Linolenic Acid